The percentage of non-standard quality (NSQ) drugs in tested samples has been steadily declining, pointing to improvements in quality assurance. Simultaneously, efforts to crack down on spurious medicines are intensifying, with a rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.
Data reveals that the share of NSQ drugs in tested samples has nearly halved — dropping from around 5 per cent in 2014-15 to 2.8 per cent in 2021-22, according to an answer given in the Lok Sabha by Bharti Pravin Pawar, then minister of state for health and family welfare, in February last year.
Meanwhile, the number of spurious drugs flagged in random sample tests surged from 83 in 2014-15 to 379 in 2021-22. The overall number of samples tested also increased from 74,199 in 2014-15 to 88,844 in 2021-22. Alongside this, prosecutions and arrests have seen a sharp uptick, with cases of prosecution rising from 152 in 2014-15 to 592 in 2021-22, and arrests climbing from 85 to 450 during the same period, shows data in Lok Sabha answers.
Bu hikaye Business Standard dergisinin October 02, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin October 02, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Industry bodies urge FinMin to ease TDS rate structure
Proposal seeks to lessen compliance burden on taxpayers and avoid litigation
After SC rap, Centre doubles penalty for stubble burning
Burning issue
Proactively made all disclosures, recusals: Sebi WTM on Cong's charges
Ananth Narayan, whole-time member (WTM), the Securities and Exchange Board of India (Sebi), has responded to allegations of conflict of interest due to personal investments.
Market regulator may water down skin-in-game rules for MF executives
The Securities and Exchange Board of India (Sebi) has shown intent to relax the skin-in-the-game norms applicable to senior executives of the mutual fund (MF) industry.
MSCI adds 5 Indian stocks to key index
MSCI added five Indian companies to its Global Standard Index late on Wednesday, a move that brokerage Nuvama said would lift the country's weighting on the index to 20 per cent, further narrowing the gap with China.
Trump's triumph: Will bulls run amok and gold, silver sparkle?
Top brokerages highlight opportunities, risks, and contradictions the new administration may offer
REIMAGINING ROLE OF AGRICULTURE
In the changed context of economic development, agriculture is seen playing a much larger role than perceived in the dominant thinking in development economics
Inside the world of mad billionaires
Two things about this book and its authors. One, this is the most unputdownable non-fiction that I have read this entire year.
Funding education
Easy financial assistance is not enough
Policy approach
RBI is acting selectively and with care
